You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microtubule inhibitor

Showing 1 - 25 of 7,439
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Tampa (Enzalutamide, Gemcitabine, Nab-paclitaxel)

Completed
  • Pancreatic Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 16, 2021

Pediatric Cancer, Solid Tumors, Lymphoma Trial in Oklahoma City (Eribulin mesylate)

Terminated
  • Pediatric Cancer
  • +2 more
  • Eribulin mesylate
  • Oklahoma City, Oklahoma
    Jimmy Everest Center for Cancer and Blood Disorders in Children
Mar 6, 2020

Ovarian Carcinosarcoma, Uterine Carcinosarcoma Trial (Eribulin Mesylate, Pembrolizumab)

Not yet recruiting
  • Ovarian Carcinosarcoma
  • Uterine Carcinosarcoma
  • (no location specified)
Jan 31, 2023

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

HER2-positive Breast Cancer Trial in Guanzhou (Eribulin mesylate injection?Pertuzumab?Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Eribulin mesylate injection、Pertuzumab、Trastuzumab
  • Guanzhou, Guangdong, China
    LI YuDong
Jul 13, 2023

Non Small Cell Lung Cancer, Advanced Lung Non-Small Cell Carcinoma, PD-L1 Gene Mutation Trial (Pembrolizumab, Pemetrexed,

Withdrawn
  • Non Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Mar 14, 2022

Diet, Autophagy Trial in San Antonio (Fasting Mimicking Diet)

Recruiting
  • Diet
  • Autophagy
  • Fasting Mimicking Diet
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Oct 29, 2023

Obesity, Insulin Resistance, Inflammation Trial run by the Eunice Kennedy Shriver National Institute of Child Health and Human

Recruiting
  • Obesity
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 16, 2022

Diffuse Large B Cell Lymphoma Trial (Polatuzumab Vedotin)

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • Polatuzumab Vedotin
  • (no location specified)
May 3, 2022

Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • quaratusugene ozeplasmid
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 12, 2022

Superficial Basal Cell Carcinoma Trial (Tirbanibulin Ointment 1%)

Not yet recruiting
  • Superficial Basal Cell Carcinoma
  • Tirbanibulin Ointment 1%
  • (no location specified)
Jan 27, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia Trial in

Recruiting
  • Acute Myeloid Leukemia Refractory
  • +2 more
  • Houston, Texas
  • +4 more
Jun 23, 2022

Breast Cancer Trial in Houston, Sugar Land (T-DM1, Trastuzumab, Lapatinib)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Advanced or Metastatic Solid Malignancies Trial in United States (Sitravatinib, Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Advanced or Metastatic Solid Malignancies
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)

Suspended
  • Triple Negative Breast Cancer
  • Anthracycline-refractory TNBC
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 28, 2022

NSCLC Metastatic Trial in La Jolla (Nivolumab + Plinabulin)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Nivolumab + Plinabulin
  • La Jolla, California
    UC San Diego Moores Cancer Center
Nov 21, 2022

Importance of the Microtubule Cytoskeleton in Oocyte Competence

Completed
  • ART
  • Vitrification and thawing
  • Lisboa, Portugal
    Instituto Valenciano de Infertilidade
Aug 3, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (MEN1611, Eribulin)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • (no location specified)
Apr 12, 2023

Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Durvalumab
  • +5 more
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

ST Elevation Myocardial Infarction, Colchicine, Cardiac Remodeling, Ventricular Trial in Jember (drug, procedure, other)

Recruiting
  • ST Elevation Myocardial Infarction
  • +2 more
  • Jember, Jawa Timur, Indonesia
    RSD dr Soebandi
Jan 23, 2023

Adenocarcinoma of the Bladder, Squamous Cell Carcinoma of the Bladder, Testicular Germ Cell Tumors Trial run by the National

Not yet recruiting
  • Adenocarcinoma of the Bladder
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

Glioblastoma Multiforme Trial in United States (TPI 287, Bevacizumab)

Suspended
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +8 more
Jul 19, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Ureter Trial in United States (Sitravatinib, Nivolumab,

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Tucson, Arizona
  • +33 more
May 21, 2021

Gastro-Oesophageal Cancer Trial in Worldwide (Regorafenib, Nivolumab, Docetaxel)

Recruiting
  • Gastro-Oesophageal Cancer
  • Scottsdale, Arizona
  • +74 more
Jan 11, 2022